Read (8469) Comments on Friday (0)
What are the listed companies of COVID-19 antigen test kit in 2022? According to Xiao Li's financial point of view, there are 20 listed companies engaged in COVID-19 antigen test kit in China A-share market, including 4 listed on Shanghai Stock Exchange and 6 listed on Shenzhen Stock Exchange. So, what are the concept stocks of COVID-19 antigen test kit? What are the leading stocks of COVID-19 antigen test kit? The following is a detailed introduction.
What are the leading stocks of COVID-19 antigen test kit?
The leading stocks of COVID-19 antigen test kit include: Jiu 'an Medical (002432), Huada Gene (300676), Daan Gene (002030), Wanfu Bio (300482), Oriental Bio (688298) and so on.
COVID-19 antigen test kit good news:
1, # Guangzhou implements classified nucleic acid testing to encourage families to bring their own antigen kit # 65438+February 1 Guangzhou epidemic prevention and control press conference put forward that classified nucleic acid testing should be implemented: nucleic acid testing should be carried out for risk posts and key personnel at a specified frequency; Implement "landing inspection" for the floating population across provinces; According to the daily needs of citizens, such as travel and medical treatment, do a good job in the service guarantee of "on-demand detection" of nucleic acids; Encourage families to bring their own antigen kits.
2. The sales volume of antigen kits has increased by more than 400 times, which will benefit the stocks related to antigen detection kits in COVID-19!
List of concept stocks of COVID-19 antigen detection kit:
1, Jiu 'an Medical (002432), the latest share price is 593 1 yuan, with a total market value of 28.567 billion yuan: the OTC kit products of the company's COVID-19 antigen home self-test have been sold locally to both C and B terminals by its subsidiary iHealth USA, and the company is actively contacting and following up all customers' orders.
2. Huada Gene (300676), the latest share price is 58.87 yuan, with a total market value of 24.367 billion yuan: the novel coronavirus antigen detection kit developed by Shenzhen Huada Yuan Yin Medical Technology Co., Ltd., a holding subsidiary of the company, passed the emergency approval of the State Medical Device Administration and obtained the medical device registration certificate. COVID-19 antigen self-test kit has been certified by EU CE.
3. Daan Gene (002030), the latest share price 17.36 yuan, with a total market value of 24.364 billion yuan. Novel coronavirus antigen rapid detection kit (colloidal gold method) developed by Zhongshan Bio, a wholly-owned subsidiary of the company, has been sent to Hongkong.
4. Wanfu Bio (300482), the latest share price is 47.0 1 yuan, with a total market value of 20.897 billion yuan: the supplier of Guangzhou antigen pilot project, the first company in China to obtain the registration certificate of COVID-19 antibody detection kit, and also the company with the largest share of antigen detection in China. Importantly, the company has no nucleic acid detection business, and focuses on antigen detection. It is one of the leading enterprises of POCT in China and has a strong first-Mover advantage.
5. Dongfang Bio (688298), the latest share price 10995438+0 yuan, and the total market value184.65 million: the company's COVID-19 antigen detection reagent was popularized and used in the European market for the first time. As the second company in the world and the first 1 company in China to obtain EU CE certification, Dongfang Bio relies on excellent technical indicators and stable and reliable quality. On February 30th, 2002112, the company got the opportunity to enter the American market. The daily output of COVID-19 antigen detection reagents of Dongfang Bio exceeds100000, and the advantages of production capacity and scale are obvious.
6. Yahuilong (688575), the latest share price is 24.65 yuan, with a total market value of139.77 million yuan: Yahuilong is a major manufacturer of antigen reagents in China, Hongkong and China, mainly engaged in independent research and development of COVID-19 novel coronavirus antigen, IgM antibody, IgG antibody and neutralizing antibody detection series diagnostic products, and won an order of 337 million yuan from Japan for COVID-19 kit, enjoying the products.
7. Kangtai Pharmaceutical (300869), the latest share price is 27. 17 yuan, and the total market value is1091700 million yuan: it has obtained novel coronavirus antigen test kit and obtained EU ce certification.
8.Top 9 Biotechnology (300406), the latest stock price 17.46 yuan, the total market value 102.8 1 100 million: the company's novel coronavirus antigen detection kit can detect the mutant strains in novel coronavirus Omicron. The company's COVID-19 detection reagent products have been sold in Italy and other countries, and the overseas sales prospects are very optimistic.
9. Mingde Bio (002932), the latest share price is 65.75 yuan, with a total market value of102.7 million: At present, the only self-test product approved by the company is novel coronavirus (20 19-nCoV) antigen test kit (self-test version), which is only certified in some overseas countries.
10, Foucault Medical (30 1087), the latest share price is 46.28 yuan, with a total market value of 9.649 billion yuan: COVID-19 antigen detection products, antibody detection products and neutralizing antibody detection independently developed and produced by the company have obtained the EU ce certificate and the export white list of the Ministry of Commerce of China, and have now started to be sold in small quantities overseas.
1 1, Cape Bio (300639), the latest share price 19.75 yuan, with a total market value of 8.68 billion yuan: novel coronavirus 20 19-nCoV nucleic acid detection kit (fluorescent PCR method) independently developed by the company, a non-COVID-19 antigen detection reagent. At present, the products have obtained the product access qualifications of countries and regions with three types of medical device registration certificates, such as EU ce certification, Brazil ANVISA certification, Australia TGA certification, DIGEMID (Peru Medical Supplies and Drug Administration) certification, COFEPRIS certification and Ethiopian Ministry of Health registration certification, and entered the emergency use list (EUL) of the World Health Organization (WHO). And obtained the export sales certificate of medical device products issued by Guangdong Drug Administration. According to the needs of overseas epidemic prevention and control, the products have been exported to Brazil, Malaysia, Sri Lanka and other countries and regions.
12, Aotai Bio (688606), the latest share price 1 18 yuan, with a total market value of 6.37 billion yuan: As one of the earliest enterprises in China to develop antibody detection products in COVID-19, the company successfully developed novel coronavirus (20 19-ncov) in February 2020.
13, Hong Qian pharmaceutical co., ltd (002550), the latest share price is 6. 16 yuan, with a total market value of 7.884 billion yuan: it has obtained the novel coronavirus antigen test kit and obtained the EU ce certification.
14, Tailin Bio (3008 13), the latest share price is 80.49 yuan, with a total market value of 6.693 billion yuan: the company started the research and development of NC membrane and the construction of the first production line, and officially put it into small batch production. Nc membrane is one of the important raw materials of COVID-19 antigen detection kit. According to the company's plan, the site construction needed to expand the production capacity of NC membrane has been completed, and relevant production equipment has been put in place and installed one after another. Some equipment is still being further optimized and debugged, and will be produced and stocked according to market demand and orders.
15, You Ningwei (30 1 166), the latest share price is 67.98 yuan, with a total market value of 5.892 billion yuan: the company is the supplier with the most complete varieties and specifications of antigens and antibodies in China; The company has core raw materials such as antigen detection, NC membrane and recombinant protein, and its products mainly include antibodies and antibody-related reagents, consumables, equipment and comprehensive technical products. The company's antibody-related reagent products include detection kits, recombinant proteins/peptides and auxiliary reagents developed based on antibody application technology. The recombinant protein is mainly used as an additive for cell culture or as a standard for drawing the standard curve of quantitative detection kit. The company's products and services cover drug discovery, preclinical research, clinical research and other aspects of drug research and development (mainly biological drugs, such as antibody drugs, recombinant protein drugs, cell therapy, etc. ).
16, Hua (002980), the latest share price is 36.9 1 yuan, and the total market value is 492 1 billion: the rapid detection kit for coronavirus antigen has been certified by the EU ce.
17, Yichang technology (002420), the latest share price 10.66 yuan, with a total market value of 4.275 billion yuan: the company's medical parts business is mainly medical structural parts and medical consumables business, and its products are COVID-19 antigen detection card parts, nucleic acid sampling tubes and deep well plates.
18, Shengtong Co., Ltd. (002599), the latest share price is 5.6 1 yuan, with a total market value of 30.1600 million: the company's business includes COVID-19 test packaging, antigen test packaging, vaccine and antigen test kit packaging, and its main customers are China Bio, zhifei Bio, Hot Scene Bio, etc.
19, Li Si Medical (6037 16), the latest share price 14.08 yuan, with a total market value of 2.866 billion yuan: the company has the production capacity of novel coronavirus (coronavirus pneumonia-19)IgM/IgG antibody detection kit (colloidal gold immunochromatography).
20.ST Toyo (002086), the latest share price is 2.9 1 yuan, and the total market value is 22.0 1 billion: novel coronavirus (20 19-nCoV)IgM/IgG antibody detection kit (colloidal gold method), a wholly-owned subsidiary of the company, was awarded by the State Administration of Medical Devices.
2 1, Novo Horizonte (688 105): The novel coronavirus (20 19-nCoV) antigen detection kit (colloidal gold method) independently developed by the company was approved for listing by the State Pharmaceutical Products Administration, and was used to detect novel coronavirus N antigen and S antigen in oropharyngeal swab and nasopharyngeal swab samples of suspected people in novel coronavirus.
The above list of "COVID-19 antigen test kit concept stocks" is ranked according to the company's market value and market share.